Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iterum Therapeutics Plc (ITRM)

Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iterum Therapeutics Plc FITZWILLIAM COURT 1ST FLOOR LEESON CLOSE DUBLIN L2 D02 IRL

www.iterumtx.com Employees: 14 P: 353-1669-4820

Description:

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.

Key Statistics

Overview:

Market Capitalization, $K 27,701
Enterprise Value, $K 33,081
Shares Outstanding, K 22,706
Annual Sales, $ 0 K
Annual Net Income, $ -38,370 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,000 K
EBIT, $ -38,260 K
EBITDA, $ -34,170 K
60-Month Beta 2.25
% of Insider Shareholders 9.20%
% of Institutional Shareholders 9.21%
Float, K 20,617
% Float 90.80%
Short Volume Ratio 0.33

Growth:

1-Year Return 76.00%
3-Year Return -85.58%
5-Year Return -96.75%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 97.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 08/14/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -2.00
EPS Growth vs. Prev Qtr 34.78%
EPS Growth vs. Prev Year 68.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/18/22

ITRM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -113.59%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.66
Interest Coverage -25.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar